Judgement will boost research to find better methods for diagnosis of gene mutations and associated health risks, say scientists
In landmark decision, the US Supreme Court on Thursday ruled that human genes may not be patented as it is a product of nature. However, synthetically created genes or DNA (cDNA) could be patented, said the court.
The Supreme court gave this judgement in the Myriad case. Myriad Genetics Inc, the respondent in the case, discovered the precise location and sequence of two human genes (BRCA1 and BRCA2), mutations of which can substantially increase the risks of breast and ovarian cancer.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.